Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations.
Davis KP, Gaffey MM, Kompelli AR, Richter GT. Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations. Pediatr Dermatol. 2022 Jan; 39(1):103-106.